Financial Advocates Investment Management Biogen Inc. Transaction History

Financial Advocates Investment Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $174,974 - $220,458	-903 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $879,557 - $1.13 Million	-3,928 Reduced 81.31%	903 $217,000
Q3 2021 Nov 04, 2021	BUY	$282.99 - $369.05 $1.07 Million - $1.39 Million	3,774 Added 357.05%	4,831 $1.37 Million
Q2 2021 Aug 03, 2021	BUY	$259.0 - $414.71 $30,821 - $49,350	119 Added 12.69%	1,057 $366,000
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $188,286 - $220,588	775 Added 475.46%	938 $262,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $34,534 - $43,741	-124 Reduced 43.21%	163 $49,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $84,237 - $110,159	287 New	287 $0

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.